A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter.
LaBarbera KM, Sheline YI, Izzo NJ, Yuede CM, Waybright L, Yurko R, Edwards HM, Gardiner WD, Blennow K, Zetterberg H, Börjesson-Hanson A, Morgan R, Davis CS, Guttendorf RJ, Schneider LS, DeKosky S, LeVine H 3rd, Grundman M, Caggiano AO, Cirrito JR, Catalano SM, Hamby ME.
LaBarbera KM, et al. Among authors: cirrito jr.
Transl Neurodegener. 2023 May 12;12(1):24. doi: 10.1186/s40035-023-00358-w.
Transl Neurodegener. 2023.
PMID: 37173791
Free PMC article.
Clinical Trial.
No abstract available.